Company / Operating Cash Flow per Share
MARAVAI LIFESCIENCES HOLDINGS, INC. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.44
FY2025
5-year range
-$0.44 / $18.54
FY2021-FY2025
Trend
-1592.7%
vs FY2024
Sector context
#96 of 212
Health Care
What the data says
Operating Cash Flow per Share changed -1593% YoY in FY2025, a notable deviation from the 6-year average annual change of +794%.
Based on SEC 10-K filings.
-0.44 in FY2025.
Declined from $0.49 to $-0.44 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 212 in Health CareTop 45% of 212This company -$0.44 Sector average -$14.72
▼
+97.0% above sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 1592.7% year-over-year.
- Ranks #96 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.44 | -1592.7% |
| FY2024 | $0.03 | -94.0% |
| FY2023 | $0.49 | -97.4% |
| FY2022 | $18.54 | +1177.3% |
| FY2021 | $1.45 | -72.4% |
| FY2020 | $5.26 | +5443.2% |
| FY2019 | $0.09 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026